Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

DC Vaccination Induces Antigen Specific Immune Responses in AML Patients: A 1-Year Interim Assessment

Judith Eckl, PhD, Silke Raffegerst, PhD, Frauke Schnorfeil, PhD, Petra Prinz-Schulz, PhD, Christiane Fingerhut, Yngvar Floisand, MD PhD, Dag Josefsen, Iris Bigalke, MD, Kai Pinkernell, MDMBA, Gunnar Kvalheim, MD PhD, Dolores Schendel, Prof., Anna Tafuri, MD

Blood (2019) 134 (Supplement_1): 3923.

https://doi.org/10.1182/blood-2019-129749

Published: 2019

Journal Articles

Personalized Immunotherapy in Follicular Lymphoma By Intranodal IFN-Dendritic-Cell Combined to Anti-CD20 Antibody

Blood (2016) 128 (22): 2976.

https://doi.org/10.1182/blood.V128.22.2976.2976

Published: 2016

Journal Articles

Dendritic Cell Production from Allogeneic Donor Cd34+ Stem Cells and Mononuclear Cells; Cancer Vaccine

Ali Unal, Ayse Birekul, Mehmet Cagri Unal, Esen Karakus, Yavuz Köker, Yusuf Ozkul, Faruk Metin Comu

Blood (2016) 128 (22): 5723.

https://doi.org/10.1182/blood.V128.22.5723.5723

Published: 2016

Journal Articles

Ex Vivo Modeling of Multiple Myeloma Provides Basis for Studying Treatment Combinations and Immunotherapy

Michael P. Chu, MD, Christopher P. Venner, MD, Irwindeep Sandhu, MD, Eva Baigorri, PhD, Jitra Kriangkum, PhD, Joanne D Hewitt, RN, BSN, NP, Andrew Belch, Linda M. Pilarski, PhD

Blood (2016) 128 (22): 2113.

https://doi.org/10.1182/blood.V128.22.2113.2113

Published: 2016

Journal Articles

Endogenous Immunoglobulin-Derived Neoepitopes Are Processed and Form a Sizeable Fraction of the HLA Class I Ligandome of Human Lymphoma Cells

Cornelis A.M. van Bergen, PhD, Dirk M. van der Steen, Michel G.D. Kester, Marvyn T. Koning, BSc, Peter A. van Veelen, PhD, Marieke Griffioen, PhD, J.H. Frederik Falkenburg, MD PhD, Mirjam H.M. Heemskerk, PhD, Hendrik Veelken, MD PhD, Marcelo A Navarrete, MD PhD

Blood (2016) 128 (22): 914.

https://doi.org/10.1182/blood.V128.22.914.914

Published: 2016

Journal Articles

Ibrutinib Enhances the Anti-Tumor Immune Response Induced By Intratumoral Injection of a TLR9 Ligand

Idit Sagiv-Barfi, Holbrook Kohrt, MD, Laura Burckhardt, Debra K Czerwinski, Ron Levy, MD

Blood (2014) 124 (21): 3121.

https://doi.org/10.1182/blood.V124.21.3121.3121

Published: 2014

Journal Articles

Redirection of Antigen-Specific T Cells to Tumor Cells Using Nanoparticle-Based Antigen-Specific Redirectors (ATRs)

Christian Schuetz, PhD, Juan C. Varela, MD PhD, Karlo Perica, Carl Haupt, Mathias Oelke, PhD, Jonathan Schneck, MDPhD

Blood (2014) 124 (21): 2753.

https://doi.org/10.1182/blood.V124.21.2753.2753

Published: 2014

Journal Articles

The Novel Anti-Myeloma Agent Chaetocin Enhances Tumor-Specific Dendritic Cell Response Via the Induction of Heat Shock Protein and Cancer Testis Antigens On Myeloma Cells

Thanh-Nhan Nguyen-Pham, Hyun Ju Lee, Huong Thi Thanh Tran, MD, PhD, Manh-cuong Vo, My-Dung Hoang, Nuri Choi, Hyeoung-Joon Kim, MD, PhD, Je-Jung Lee, MD, PhD

Blood (2012) 120 (21): 4066.

https://doi.org/10.1182/blood.V120.21.4066.4066

Published: 2012

Journal Articles

Composition of PBMC Population and Functionality of T- and NK-Cells in AML Patients Receiving Cytotoxic Maintenance Therapy,

Felix S Lichtenegger, MD, Robin Lorenz, Patrick Palluch, Ulrich Hoffmueller, MBA, PhD, Jan Braess, MD, Wolfgang Hiddemann, PhD, Barbara Beck, PhD, Marion Subklewe, MD

Blood (2011) 118 (21): 3601.

https://doi.org/10.1182/blood.V118.21.3601.3601

Published: 2011

Journal Articles

Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients

Yanran Cao, M.D., Sacha Gnjatic, Ph.D., Vincent G. Brichard, M.D. Ph.D., Tim Luetkens, M.D., Sebastian Kobold, M.D., Katrin Bartels, Nasser Altorki, M.D., Friedrich Haag, M.D., Gerd Ritter, M.D., Carsten Bokemeyer, M.D., Lloyd J Old, M.D., Nicolaus Kroeger, M.D., Djordje Atanackovic, M.D.

Blood (2011) 118 (21): 5087.

https://doi.org/10.1182/blood.V118.21.5087.5087

Published: 2011

Journal Articles

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

Mohammad Hojjat-Farsangi, PhD, Fariba Mozaffari, Ph.D, Amir Hossein Daneshmanesh, MD, Ph.D, Anders Osterborg, MD, PhD, Fazel Shokri, Ph.D, Håkan Mellstedt, MD, Ph.D

Blood (2011) 118 (21): 1771.

https://doi.org/10.1182/blood.V118.21.1771.1771

Published: 2011

Journal Articles

Strong Antibody Responses Against a Unique Region of CT-Antigen SSX-2 Are Induced After Allogeneic Stem Cell Transplantation and Correlate with Clinical Remission In Patients with Multiple Myeloma

Sebastian Kobold, Tim Luetkens, Yanran Cao, Corinna Eberhardt, Sinje Tams, Britta Marlen Bartels, Katrin Bartels, Sabrina Meyer, Friedrich Haag, Carsten Bokemeyer, Axel R. Zander, MD, Nicolaus Kröger, Djordje Atanackovic

Blood (2010) 116 (21): 1900.

https://doi.org/10.1182/blood.V116.21.1900.1900

Published: 2010

Journal Articles

T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1

Mohammad Hojjat -Farsangi, Ph.D, Amir Hossein Daneshmanesh, MD, Mahmood Jeddi-Tehrani, Ph.D, Anders Osterborg, MD, PhD, Fazel Shokri, Ph.D, Håkan Mellstedt, MD, Ph.D, Hodjattallah Rabbani, Ph.D

Blood (2010) 116 (21): 3603.

https://doi.org/10.1182/blood.V116.21.3603.3603

Published: 2010

Journal Articles

HLA-Dependent Immune Selection Pressure on the Idiotype Is Predominantly Driven by Somatic Hypermutation In Malignant Lymphoma but Also Modulates Vh Usage In Normal B Cells

Dimitrios Papaioannou, M.D., Anna-Maria Strothmeyer, M.D., Marcus Dühren-von Minden, M.Sc., Marcelo A. Navarrete, M.D., Katja Zirlik, MD, Kristina Heining-Mikesch, M.D., Hendrik Veelken, M.D., Ph.D.

Blood (2010) 116 (21): 3132.

https://doi.org/10.1182/blood.V116.21.3132.3132

Published: 2010

Journal Articles

Prediction of MHC Class I-Restricted Immunogenic Epitopes of B-Cell Receptors Indicates T Cell-Mediated Immunosurveillance of Malignant B Cell Clones.

Anna-Maria Strothmeyer, Marcus Duehren-von Minden, MSc, Marcelo A Navarrete, MD, Kristina Heining-Mikesch, MD, Hendrik Veelken, MD

Blood (2009) 114 (22): 1949.

https://doi.org/10.1182/blood.V114.22.1949.1949

Published: 2009

Journal Articles

Functional PRAME Specific T Cells Can Be Cultured From CD8+ Cells From Healthy Donors but Not From Patients at First CR: Implications for Immunotherapeutic Strategies in AML.

Willemijn van den Ancker, Theresia M Westers, PhD, Hetty J Bontkes, PhD, Dewi Wulandari, Erik Hooijberg, PhD, Anita GM Stam, Saskia JAM Santegoets, PhD, Gert J Ossenkoppele, MD, PhD, Tanja D de Gruijl, PhD, Arjan A van de Loosdrecht, MD, PhD

Blood (2009) 114 (22): 4139.

https://doi.org/10.1182/blood.V114.22.4139.4139

Published: 2009

Journal Articles

Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, An Immunogenic Cancer Testis Antigen

Jason A Dubovsky, B.S., Douglas G McNeel, M.D., Ph.D., John J. Powers, B.S., Eduardo M. Sotomayor, MD, Javier Pinilla, MD, PhD

Blood (2008) 112 (11): 4207.

https://doi.org/10.1182/blood.V112.11.4207.4207

Published: 2008

Journal Articles

Specific Immune Response Induced by PML-Rarα-hIL-2 Vaccine in BALB/C Mice

Yangqiu Li, Dongzhi Cen, Yubing Zhou, Lijian Yang, Gang Hu, Shaohua Chen, Chen Lin

Blood (2008) 112 (11): 4009.

https://doi.org/10.1182/blood.V112.11.4009.4009

Published: 2008

Journal Articles

A Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy with Mitumprotimut-T (ID-KLH) and GM-CSF Following Rituximab in Patients with CD20+ Follicular Lymphoma

Arnold S. Freedman, MD, Sattva Neelapu, MD, Craig R Nichols, MD, Michael Robertson, MD, Benjamin Djulbegovic, MD, PhD, Jane N. Winter, MD, Daniel Gold, PhD, John Bender, PharmD, Morgan Stewart, PhD, Richard G. Ghalie, MD, MBA, Paul A. Hamlin, Jr., MD

Blood (2008) 112 (11): 236.

https://doi.org/10.1182/blood.V112.11.236.236

Published: 2008

Journal Articles

Expression of Cancer Testis Antigens as Potential Targets for Immunotherapy Is Retained Following Treatment in Multiple Myeloma.

Mark van Duin, Surinder S. Sahota, Yvonne de Knegt, Annemiek Broyl, Debora Joseph-Pietras, George Mulligan, Barb Bryant, Pieter Sonneveld

Blood (2008) 112 (11): 1722.

https://doi.org/10.1182/blood.V112.11.1722.1722

Published: 2008

NARROW

DC Vaccination Induces Antigen Specific Immune Responses in AML Patients: A 1-Year Interim Assessment

Personalized Immunotherapy in Follicular Lymphoma By Intranodal IFN-Dendritic-Cell Combined to Anti-CD20 Antibody

Dendritic Cell Production from Allogeneic Donor Cd34+ Stem Cells and Mononuclear Cells; Cancer Vaccine

Ex Vivo Modeling of Multiple Myeloma Provides Basis for Studying Treatment Combinations and Immunotherapy

Endogenous Immunoglobulin-Derived Neoepitopes Are Processed and Form a Sizeable Fraction of the HLA Class I Ligandome of Human Lymphoma Cells

Ibrutinib Enhances the Anti-Tumor Immune Response Induced By Intratumoral Injection of a TLR9 Ligand

Redirection of Antigen-Specific T Cells to Tumor Cells Using Nanoparticle-Based Antigen-Specific Redirectors (ATRs)

The Novel Anti-Myeloma Agent Chaetocin Enhances Tumor-Specific Dendritic Cell Response Via the Induction of Heat Shock Protein and Cancer Testis Antigens On Myeloma Cells

Composition of PBMC Population and Functionality of T- and NK-Cells in AML Patients Receiving Cytotoxic Maintenance Therapy,

Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

Strong Antibody Responses Against a Unique Region of CT-Antigen SSX-2 Are Induced After Allogeneic Stem Cell Transplantation and Correlate with Clinical Remission In Patients with Multiple Myeloma

T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1

HLA-Dependent Immune Selection Pressure on the Idiotype Is Predominantly Driven by Somatic Hypermutation In Malignant Lymphoma but Also Modulates Vh Usage In Normal B Cells

Prediction of MHC Class I-Restricted Immunogenic Epitopes of B-Cell Receptors Indicates T Cell-Mediated Immunosurveillance of Malignant B Cell Clones.

Functional PRAME Specific T Cells Can Be Cultured From CD8+ Cells From Healthy Donors but Not From Patients at First CR: Implications for Immunotherapeutic Strategies in AML.

Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, An Immunogenic Cancer Testis Antigen

Specific Immune Response Induced by PML-Rarα-hIL-2 Vaccine in BALB/C Mice

A Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy with Mitumprotimut-T (ID-KLH) and GM-CSF Following Rituximab in Patients with CD20+ Follicular Lymphoma

Expression of Cancer Testis Antigens as Potential Targets for Immunotherapy Is Retained Following Treatment in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only